Inventor · disambiguated record
Wenqing Jiang
Also filed as: JIANG WENQING
7 granted patents·12 pending applications·15 citations·filing 2016–2025
77Inventor score
Files withCONCEPT TO MEDICINE BIOTECH CO LTD7ABL BIO INC4GLAXOSMITHKLINE IP DEV LTD3I MAB BIOPHARMA CO LTD2I MAB BIOPHARMA US LTD2
Top patents by PatentIndex Score
19 records- 0189US9914781B1Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 13, 2018·10 cites·6 claims
- 0282US11261259B2Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereofI MAB BIOPHARMA US LTD·Filed 2020·Granted Mar 1, 2022·1 cites·19 claims
- 0381US10577421B2Anti-LAG-3 antibodies and uses thereofI MAB·Filed 2018·Granted Mar 3, 2020·3 cites·11 claims
- 0477US12195538B2Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereofABL BIO INC·Filed 2019·Granted Jan 14, 2025·1 cites·10 claims
- 0574US2024209109A1Tumor antigen-dependent cd40 agonists antibodiesCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 0674US2024287208A1Tumor antigen-dependent cd40 agonists antibodiesCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 0774US2024247073A1Tumor antigen-dependent cd40 agonists antibodiesCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 0865US11414485B2Anti-LAG-3 antibodies and uses thereofI MAB BIOPHARMA US LTD·Filed 2019·Granted Aug 16, 2022·0 cites·14 claims
- 0964US2025145718A1Anti-pd-l1/anti-4-1bb bispecific antibodies and uses thereofABL BIO INC·Filed 2025·Application pending·0 cites
- 1062US2025297032A1Human antibodies against fap-alphaCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1160US2021347902A1Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 1259US2025074995A1Multispecific constructs and uses thereofI MAB BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1359US2025154277A1Anti-5t4 antibodies and uses thereofCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1459US2025368744A1Anti-ccr8 antibodies and uses thereofCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1555US2025313632A1Anti-b7-h3 antibodies and uses thereofCONCEPT TO MEDICINE BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1652US2024209093A1Single domain pd-l1 antibodiesI MAB BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1748US11078287B2Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 3, 2021·0 cites·18 claims
- 1847US2023192861A1Anti-pd-l1/anti-b7-h3 multispecific antibodies and uses thereofABL BIO INC·Filed 2020·Application pending·0 cites
- 1946US12173070B2Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereofABL BIO INC·Filed 2019·Granted Dec 24, 2024·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Wenqing Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →